Cambridge Investment Research Advisors, Inc. - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 55 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$14
-30.0%
16,500
-5.7%
0.00%
Q2 2023$20
+11.1%
17,5000.0%0.00%
Q1 2023$18
-10.0%
17,5000.0%0.00%
Q4 2022$20
-99.9%
17,500
-32.7%
0.00%
Q3 2022$29,000
-23.7%
26,0000.0%0.00%
Q2 2022$38,000
-36.7%
26,0000.0%0.00%
Q1 2022$60,000
-31.8%
26,000
-18.5%
0.00%
Q4 2021$88,000
-65.8%
31,900
-25.6%
0.00%
-100.0%
Q3 2021$257,000
+74.8%
42,850
+41.9%
0.00%0.0%
Q2 2021$147,000
+88.5%
30,200
-3.8%
0.00%
Q1 2021$78,000
+188.9%
31,400
+214.0%
0.00%
Q4 2020$27,00010,0000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q1 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders